ANDA 202592, held by Taro. Desloratadine.
As of Nov 16, 2026, ANDA 202592 (Desloratadine), held by Taro, was first approved by FDA on Jun 30, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 30, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desloratadine0.5MG/ML ยท solution;oral | Desloratadine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters